Spina v. United States

CourtDistrict Court, S.D. New York
DecidedNovember 18, 2024
Docket7:23-cv-05885
StatusUnknown

This text of Spina v. United States (Spina v. United States) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Spina v. United States, (S.D.N.Y. 2024).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK

JAMES SPINA,

Petitioner, No. 23-CV-5885 (KMK) v.

UNITED STATES OF AMERICA,

Respondent.

UNITED STATES OF AMERICA

No. 18-CR-625 (KMK) v. OPINION & ORDER JAMES SPINA,

Defendant.

Appearances: James Spina Pro Se Petitioner

Nicholas S. Bradley, Esq. United States Attorney’s Office New York, NY Counsel for Respondent

KENNETH M. KARAS, United States District Judge: James Spina (“Petitioner”) has filed a Petition for a Writ of Habeas Corpus (the “Petition”), pursuant to 28 U.S.C. § 2255, to vacate, set aside, or correct his judgment of conviction, entered on his April 13, 2021, which included a sentence of 108 months’ imprisonment, imposed after Spina pled guilty, pursuant to a plea agreement, to one count of conspiracy to commit healthcare fraud, in violation of Title 18, United States Code, Section 1349. (See generally Pet. for Writ of Habeas Corpus (“Pet.”) (Civ. Dkt. No. 1, Case No. 23-CV- 5885; Cr. Dkt. No. 249, Case No. 18-CR-625).)1 For the following reasons, the Petition is denied. I. Background

A. Factual Background 1. Offense Conduct The charges against Petitioner arose from an investigation into a long-running scheme operated out of his Dolson Avenue Medical practice (“DAM”) in Middletown, New York that provided a variety of pain management and rehabilitation services. (Final Presentence Investigation Rep. (“PSR”) ¶ 13 (Cr. Dkt. No. 32).)2 Besides DAM, at least nine other corporations billed from the DAM location during the relevant period. (PSR ¶ 14). A number of other individuals nominally owned the DAM Practice and its affiliated businesses. (PSR ¶¶ 16; 17.) In reality, however, Petitioner and his brother, both practicing chiropractors, owned and operated the different businesses, including the medical corporations. (Id. at ¶ 16.) They made critical decisions regarding finances, employees, and, most importantly, billing. (Id. at ¶ 16.) Indeed, Petitioner operated the DAM Practice to maximize reimbursements

and his own profits. (Id. at ¶ 16.) By masking the ownership and control of the associated

1 Certain of the Parties’ papers were filed on Petitioner’s criminal docket, Case No. 18- CR-625, and certain on Petitioner’s civil docket, Case No. 23-CV-5885-1. The docket citations indicate on which docket each document was filed (“Civ.” for documents on the civil docket, and “Cr.” for documents on the criminal docket). 2 “Mot.” refers to the Section 2255 motion, and citations to page numbers in the motion refer to the page numbers assigned by CM/ECF; “PSR” refers to the Presentence Investigation Report prepared by the United States Probation Office in connection with the defendant’s sentencing. 2 businesses, Petitioner used different entities to bill for medical services for a single patient. (Id. at ¶ 21.). This reduced the volume of bills submitted by any one corporation, and thus decreased the risk of triggering alarm from insurers. (Id. at ¶¶ 16-17, 21.) Petitioner and his co-conspirators engaged in numerous fraudulent practices, including billing for unnecessary or never-performed services or procedures, double billing, i.e., billing

two insurance providers for the same medical service or procedure, and altering and falsifying medical records. (Id. at ¶¶ 23-29.) To conceal the fraudulent scheme, Petitioner obstructed audits conducted by Medicare and other insurance providers by fabricating and withholding patient records. (Id. at ¶ 16). As part of Petitioner’s fraudulent practices, Petitioner encouraged Charles Bagley, a neurologist who worked at the Practice, to administer and bill for lucrative facet injections, despite being aware that several of Bagley’s patients suffered adverse reactions from that delicate and dangerous procedure. (Id. at ¶ 33.) In March 2017, a patient of the DAM Practice died shortly after receiving a facet injection from Bagley. (Id.)

On August 29, 2018, a grand jury returned an Indictment charging Petitioner and others with conspiracy to commit healthcare fraud (Count One), healthcare fraud (Count Two), and obstruction of a federal audit (Count Three). (See Indictment (Cr. Dkt. No. 2); PSR ¶ 34.) 2. Guilty Plea On May 2, 2019, Petitioner, represented by his counsel, and the Government executed a Plea Agreement, which contained the terms under which Petitioner agreed to plead guilty to conspiracy to commit healthcare fraud, as charged in Count One of the Indictment. (See Gov’t Mem. in Opp., Ex. A, at 1-7 (Cr. Dkt. No. 253).

3 In the Plea Agreement, the Parties stipulated that the United States Sentencing Guidelines (the “Guidelines” or “U.S.S.G.”) applied to Petitioner’s sentencing as follows: The base offense level was six, under U.S.S.G. § 2B1.1(a)(2), because the offense carried a statutory maximum prison term of 10 years; two levels were added, under U.S.S.G. § 2B1.1(b)(2)(A)(i), because the offense involved 10 or more victims; two levels were added, under U.S.S.G. § 2B1.1(b)(10)(C),

because the offense involved sophisticated means; two levels were added, under U.S.S.G. § 2B1.1(b)(16)(A), because the offense involved conscious or reckless risk of death or serious bodily injury; four levels were added, under U.S.S.G § 3B1.1(a), because Petitioner was an organizer or leader of a criminal activity that involved five or more participants or was otherwise extensive; and three levels were subtracted, under U.S.S.G. § 3E1.1, for acceptance of responsibility. (Id. at 2-3.) The Parties disputed two aspects of the Guidelines calculation. First, they disputed the applicable loss amount under U.S.S.G. § 2B1.1(b)(1): the Government contended that a 22-level enhancement applied because the loss exceeded $25 million but did not exceed $65 million, and

Petitioner contended that a 16-level enhancement applied because the loss exceeded $1.5 million but did not exceed $3.5 million. Second, the Parties disputed the applicability of a two-level enhancement, under U.S.S.G. § 2B1.1(b)(7), for loss to a government healthcare program—here, Medicare—exceeding $1 million. (Id. at 2.) The bottom line is that the Parties agreed in the Plea Agreement that the total offense level was either 29 or 37. (Id. at 3.) They further agreed that Petitioner had zero criminal history points, resulting in a Criminal History Category of I. (Id.). As a result, the Parties agreed that the applicable Guidelines range was either: (i) 87 to 108 months’ imprisonment, if the loss amount was more than $1.5 million but no greater than $3.5 million and the loss to Medicare did

4 not exceed $1 million; or (ii) 210 to 262 months’ imprisonment, if the loss amount was more than $25 million but no greater than $65 million and the loss to Medicare exceeded $1 million. However, under U.S.S.G. § 5G1.2, because Count One carried a statutory maximum of 120 months’ imprisonment, the resulting Guidelines range stipulated in the Plea Agreement became 87 to 120 months’ imprisonment (the “Stipulated Guidelines Range”). (Id.).

In addition to stipulating to the applicable Guidelines range, the Parties stipulated “that neither a downward nor an upward departure from the Stipulated Guidelines Range” was warranted. (Id.). The Parties further agreed not to seek “any departure or adjustment pursuant to the Guidelines that is not set forth” in the Plea Agreement or “in any way suggest that the Probation Office or the Court consider such a departure or adjustment under the Guidelines.” (Id.). The Parties agreed, however, that “either party may seek a sentence outside of the Stipulated Guidelines Range based upon the factors to be considered in imposing a sentence pursuant to Title 18, United States Code, Section 3553(a),” and that “nothing in this Agreement limits the right of the parties . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bobby v. Van Hook
558 U.S. 4 (Supreme Court, 2009)
MacHibroda v. United States
368 U.S. 487 (Supreme Court, 1962)
Coppedge v. United States
369 U.S. 438 (Supreme Court, 1962)
McCarthy v. United States
394 U.S. 459 (Supreme Court, 1969)
Strickland v. Washington
466 U.S. 668 (Supreme Court, 1984)
Kimmelman v. Morrison
477 U.S. 365 (Supreme Court, 1986)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
United States v. Caracappa
614 F.3d 30 (Second Circuit, 2010)
Yick Man Mui v. United States
614 F.3d 50 (Second Circuit, 2010)
Bolivar Irizarry v. United States
508 F.2d 960 (Second Circuit, 1975)
Scott C. Ciak v. United States
59 F.3d 296 (Second Circuit, 1995)
United States v. William Bokun
73 F.3d 8 (Second Circuit, 1995)
John A. Cuoco v. United States
208 F.3d 27 (Second Circuit, 2000)
George Lindstadt v. John P. Keane, Superintendent
239 F.3d 191 (Second Circuit, 2001)
Gonzalez v. United States
722 F.3d 118 (Second Circuit, 2013)
Rodriguez v. United States
679 F. App'x 41 (Second Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Spina v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/spina-v-united-states-nysd-2024.